Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Asia

$500 SAVINGS END IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
19 - 21 October, 2026
The Westin Miyako KyotoKyoto, Japan

Alfred Lim, PhD
Director of Lab Research at Etcembly Ltd., UK
Speaker

Profile

Alfred is Director of Lab Research at Etcembly, where he leads the development of new TCR drug candidates from discovery through to preclinical characterization and translational development. He was previously Head of Discovery at Theolytics and was responsible for candidate optimisation and lead nomination across the different pipeline programs. Alfred trained in immunology at the MRC Laboratory of Molecular Biology, Cambridge and holds a PhD in Molecular Immunology from the University of Cambridge.

Agenda Sessions

  • EMLy™: Powering Smarter, Faster, and Scalable AI-Guided Biologics Development

    12:00